May 9, 2024
Memphis, Tennessee television station Action News 5 featured research from the University of Cincinnati's Laura Ngwenya and Jed Hartings that is testing the first treatments for spreading depolarizations, abnormal brain activity also called a "brain tsunami."
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
May 24, 2024
The University of Cincinnati's Reena Shah spoke with Healthline on ways for parents to better manage migraines.
May 22, 2024
TCT MD included comments from the University of Cincinnati's Eva Mistry in a story recapping trial data presented at the European Stroke Organisation Conference that found clot-busting drug tenectaplase is becoming a first-choice treatment in certain situations.
March 3, 2025
A new scientific statement from the American Heart Association highlights the evolution of the cardiac critical care specialty and the challenges faced in today’s rapidly changing health care environment. The new statement serves as an update to a 2012 statement and was published Feb. 13 in in the journal Circulation.
March 18, 2025
The Cincinnati Business Courier and Spectrum News highlighted the University of Cincinnati receiving a $2.3 million grant to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.
March 19, 2025
The University of Cincinnati's Joseph Broderick was featured in a Medscape article commenting on new treatments and advancements in the field of poststroke recovery research.
March 20, 2025
OncLive and MedPage Today highlighted research presented by the University of Cincinnati Cancer Center's Thomas Herzog that found a combination therapy of afuresertib and paclitaxel did not lead to better survival outcomes when compared to only treating with paclitaxel in patients with platinum-resistant ovarian cancer.
March 24, 2025
The University of Cincinnati Cancer Center's Amanda Jackson was featured in a MedPage Today article commenting on new research that found adding metformin as a combination therapy was tied to deep responses and prolonged progression-free survival in some patients with recurrent estrogen receptor-positive endometrial cancer.
March 25, 2025
Local 12 highlighted University of Cincinnati Cancer Center researcher Davendra Sohal and patient Ron Solomon who is enrolled in a pancreatic cancer trial targeting a genetic mutation called KRAS.